Recommended Naloxone Dosing for Suspected Opioid Overdose
For suspected opioid overdose, the recommended initial dose of naloxone is 0.04-0.4 mg IV/IM, titrating up to 2 mg as needed if there is inadequate response, with higher doses potentially required for atypical opioids or massive overdose. 1
Adult Dosing
Initial Dosing
- IV/IO route (preferred): 0.04-0.4 mg initially 2, 1
- IM route: 0.4 mg initially (if IV access unavailable) 3
- Intranasal route: 2-4 mg (comparable efficacy to IM route) 1, 4
Titration and Repeat Dosing
- Repeat doses every 2-3 minutes if inadequate response 2, 3
- Escalate dosing up to 2 mg if initial dose ineffective 2
- Consider higher doses for atypical opioids (e.g., propoxyphene) or massive overdose 2
- If no response after 10 mg total, question opioid-induced toxicity 3
Pediatric Dosing
- Initial dose: 0.01 mg/kg IV/IM/SC 3
- If inadequate response: May administer subsequent dose of 0.1 mg/kg 3
- Neonates: 0.01 mg/kg IV/IM/SC 3
Route Selection Considerations
- IV route advantages: Allows for titration, faster onset of action 4
- Intranasal advantages: Needle-free administration, comparable efficacy to IM 1, 4
- IM route disadvantages: Difficult to titrate, slower onset, needle exposure risk 4
Important Clinical Considerations
Balancing Reversal vs. Withdrawal
- Start with lower doses (0.04-0.4 mg) in opioid-dependent patients to avoid precipitating severe withdrawal 2, 1, 5
- Higher initial doses may be appropriate in non-opioid-dependent patients with life-threatening overdose 3
Duration of Action
- Naloxone's duration of action is approximately 45-70 minutes 2
- Long-acting opioids (e.g., methadone) may cause respiratory depression outlasting naloxone's effects 2, 1
- Continuous observation for at least 4-6 hours after the last naloxone dose is recommended 1
Potential Complications
- Acute withdrawal syndrome: May include agitation, hypertension, tachycardia, vomiting 2, 6
- Resedation: Can occur as naloxone wears off, especially with long-acting opioids 2, 1
- Pulmonary complications: Including non-cardiogenic pulmonary edema 1, 6
Monitoring After Administration
- Continue respiratory support even after naloxone administration 1
- Monitor vital signs, level of consciousness, and respiratory status 1
- Be prepared to administer repeated doses if respiratory depression recurs 2, 1
- Consider extended observation (12-24 hours) for long-acting opioid overdose 1
Pitfalls to Avoid
- Delaying ventilatory support while waiting for naloxone to take effect 1
- Administering excessive initial doses to opioid-dependent patients 1, 5
- Premature discharge before adequate observation period 1
- Focusing solely on opioid reversal without addressing potential co-ingestions 1
Remember that naloxone is an adjunct to respiratory support, not a replacement. Always ensure adequate ventilation while administering naloxone for suspected opioid overdose.